Biological Products, (No Diagnostic Substances)·LEXINGTON, MA
All Filings(1000 total)
TypeDateAccessionPeriodSize
4
Mar 9, 2026
0001193125-26-0985284
Mar 6, 2026
7.1 KB
4
Feb 24, 2026
0001193125-26-0669484
Feb 20, 2026
7.1 KB
4
Feb 9, 2026
0001193125-26-0427724
Feb 6, 2026
7.1 KB
4
Jan 26, 2026
0001193125-26-0225614
Jan 23, 2026
7.1 KB
SCHEDULE 13D
Jan 23, 2026
0002106704-26-000001
—
13.6 KB
3
Jan 16, 2026
0001193125-26-0153403
Jan 8, 2026
15.0 KB
8-K
Jan 16, 2026
0001193125-26-0146788-K
Jan 15, 2026
770.2 KB
8-K
Jan 14, 2026
0001193125-26-0129228-K
Jan 8, 2026
145.8 KB
4
Jan 12, 2026
0001193125-26-0103604
Jan 9, 2026
7.1 KB
8-K
Jan 8, 2026
0001193125-26-0077068-K
Jan 3, 2026
139.2 KB
4
Jan 5, 2026
0001193125-26-0023954
Jan 2, 2026
4.7 KB
4
Jan 5, 2026
0001193125-26-0023914
Jan 2, 2026
5.7 KB
S-3ASR
Dec 29, 2025
0001193125-25-335494S-3ASR
—
362.3 KB
4
Dec 29, 2025
0001193125-25-3352884
Dec 26, 2025
7.1 KB
4
Dec 15, 2025
0001193125-25-3191864
Dec 12, 2025
7.1 KB
4
Dec 1, 2025
0001193125-25-3038594
Nov 28, 2025
7.1 KB
4
Nov 17, 2025
0001193125-25-2846004
Nov 14, 2025
7.1 KB
10-Q
Nov 10, 2025
0001193125-25-27455410-Q
Sep 30, 2025
12.6 MB
8-K
Nov 10, 2025
0001193125-25-2732668-K
Nov 10, 2025
336.9 KB
4
Nov 5, 2025
0001193125-25-2668754
Oct 31, 2025
7.1 KB
SCHEDULE 13G/A
Oct 30, 2025
0000102909-25-000038
—
6.0 KB
4
Oct 21, 2025
0001193125-25-2450894
Oct 17, 2025
7.1 KB
8-K
Oct 9, 2025
0001193125-25-2358198-K
Oct 8, 2025
142.3 KB
4
Oct 6, 2025
0001193125-25-2318574
Oct 3, 2025
7.1 KB
4
Oct 3, 2025
0001193125-25-2301004
Oct 1, 2025
4.6 KB
25 filings shown
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer.